We are live on
!
Find out more
QOP
Quinn Opportunity Partners Portfolio holdings
AUM
$1.92B
1-Year Est. Return
31.26%
This Fund
S&P 500
This Quarter
Est. Return
+9.7%
1 Year Est. Return
+31.26%
3 Year Est. Return
+67.23%
5 Year Est. Return
+49.99%
10 Year Est. Return
+245.23%
AUM
$1.2B
AUM Growth
-$262M
(-18%)
Cap. Flow
-$322M
Cap. Flow
% of AUM
-26.96%
Top 10 Holdings %
Top 10 Hldgs %
28.3%
Holding
447
New
49
Increased
72
Reduced
87
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$13.2M |
| 2 |
PG&E
PCG
|
+$13.1M |
| 3 |
Mid-America Apartment Communities
MAA
|
+$12.5M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$12.4M |
| 5 |
PepsiCo
PEP
|
+$9.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JNPR
Juniper Networks
JNPR
|
+$29.9M |
| 2 |
Microsoft
MSFT
|
+$22.4M |
| 3 |
CVS Health
CVS
|
+$21.6M |
| 4 |
Robinhood
HOOD
|
+$18.4M |
| 5 |
Netflix
NFLX
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.85% |
| 2 | Communication Services | 24.25% |
| 3 | Healthcare | 10.99% |
| 4 | Financials | 6.61% |
| 5 | Consumer Staples | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Roivant Sciences
ROIV
$26.2B
| $451K | 0.04% |
+40,000
| New | +$434K |
|
252
Vera Therapeutics
VERA
$2.36B
| $448K | 0.04% |
+19,000
| New | +$427K |
|
|
GES
253
DELISTED
Guess Inc
GES
| $444K | 0.04% |
36,700
-471,373
| -93% | -$5.27M |
|
254
MKS Inc
MKSI
$20.6B
| $438K | 0.04% |
4,410
| – | – |
|
255
UBS Group
UBS
$176B
| $427K | 0.04% |
+12,617
| New | +$390K |
|
256
Biohaven
BHVN
$2.21B
| $423K | 0.04% |
+30,000
| New | +$535K |
|
|
SFIX
257
Stitch Fix
SFIX
$560M
| $413K | 0.03% |
111,600
-101,982
| -48% | -$382K |
|
258
Wells Fargo
WFC
$264B
| $401K | 0.03% |
5,000
-43,471
| -90% | -$3.13M |
|
259
Under Armour Class C
UA
$2.53B
| $389K | 0.03% |
+60,000
| New | +$354K |
|
260
eHealth
EHTH
$43.9M
| $387K | 0.03% |
89,000
| – | – |
|
|
ACB
261
Aurora Cannabis
ACB
$185M
| $382K | 0.03% |
90,100
| – | – |
|
262
Krispy Kreme
DNUT
$577M
| $380K | 0.03% |
130,754
| – | – |
|
263
RH
RH
$3.71B
| $378K | 0.03% |
+2,000
| New | +$371K |
|
264
Heron Therapeutics
HRTX
$92.9M
| $363K | 0.03% |
175,344
-104,656
| -37% | -$214K |
|
265
SunPower Inc
SPWR
$53.8M
| $358K | 0.03% |
+194,526
| New | +$336K |
|
266
NCR Voyix
VYX
$1.14B
| $352K | 0.03% |
30,000
| – | – |
|
267
Nu Skin
NUS
$267M
| $350K | 0.03% |
43,866
| – | – |
|
268
Dana Inc
DAN
$3.06B
| $343K | 0.03% |
+20,000
| New | +$299K |
|
269
Mattel
MAT
$4.23B
| $341K | 0.03% |
17,296
-29,500
| -63% | -$525K |
|
270
Carvana
CVNA
$77.9B
| $337K | 0.03% |
5,000
-49,500
| -91% | -$2.71M |
|
271
J. Jill
JILL
$283M
| $337K | 0.03% |
23,000
| – | – |
|
272
Sana Biotechnology
SANA
$980M
| $328K | 0.03% |
120,100
| – | – |
|
273
NetApp
NTAP
$37.2B
| $322K | 0.03% |
3,020
| – | – |
|
274
Intel
INTC
$513B
| $320K | 0.03% |
+14,302
| New | +$296K |
|
275
Halozyme
HALO
$12.2B
| $312K | 0.03% |
6,000
-1,000
| -14% | -$56.9K |
|
Similar funds
RCAG
6CM
DCM
CC
MC
BOH
HC
IAN
Quinn Opportunity Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Quinn Opportunity Partners held 447 positions worth $1.2B, down 18% from $1.46B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Quinn Opportunity Partners withdrew a net $322M in Q2 2025, closing 90 positions and reducing 87 holdings. Its most notable exit was Juniper Networks, an estimated $29.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 21% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Quinn Opportunity Partners opened a new position in iShares 7-10 Year Treasury Bond ETF worth $13.4M.
- Quinn Opportunity Partners's largest Q2 2025 buy was iShares 7-10 Year Treasury Bond ETF: 140,000 shares worth $13.4M.
- Quinn Opportunity Partners added most to PG&E in Q2 2025, an estimated $13.1M increase.
- Quinn Opportunity Partners's biggest Q2 2025 reduction was CVS Health, cutting an estimated $21.6M.
- Quinn Opportunity Partners fully exited Juniper Networks in Q2 2025, selling an estimated $29.9M.
- Quinn Opportunity Partners's ten largest holdings make up 28% of its $1.2B portfolio in Q2 2025.
- Quinn Opportunity Partners opened 49 new positions and closed 90 in Q2 2025.
- Quinn Opportunity Partners's portfolio value fell 18% quarter-over-quarter to $1.2B.
Based on Quinn Opportunity Partners's 13F filing for Q2 2025, filed 8 Aug 2025.